CVI Holdings’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

CVI Holdings’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$6.39K	–	628
2022 Q4	$6.39K	Hold	100,000	–	–	﹤0.01%	423
2022 Q3	$6K	Hold	100,000	–	–	﹤0.01%	708
2022 Q2	$4K	Hold	100,000	–	–	﹤0.01%	870
2022 Q1	$24K	Hold	100,000	–	–	﹤0.01%	750
2021 Q4	$65K	Hold	100,000	–	–	﹤0.01%	726
2021 Q3	$66K	Hold	100,000	–	–	﹤0.01%	714
2021 Q2	$86K	Hold	100,000	–	–	0.01%	623
2021 Q1	$61K	Buy	+100,000	New	+$70.5K	﹤0.01%	537

CVI Holdings's BIOTW Position: Q1 2023 in Review

CVI Holdings sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 100,000 shares — an estimated $6.39K sold.

CVI Holdings first reported a position in BIOTW in Q1 2021 and held it in 8 quarters. The position peaked at $86K in Q2 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

CVI Holdings reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
CVI Holdings sold 100,000 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $6.39K.
CVI Holdings first reported a position in Biotech Acquisition Company Warrant in Q1 2021 and held it in 8 quarters.
CVI Holdings's Biotech Acquisition Company Warrant position peaked at $86K in Q2 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.